BioCentury | Feb 24, 2021
Deals

Feb. 23 Quick Takes: BGI raises $300M, plus a $230M C round for Clover, Day One, Waksal’s Graviton, Asalyxa

...KGaA dealOn the heels of a $130 million series B round led by RA Capital, Day One Biopharmaceuticals LLC...
...kinase kinase 2ROCK2 - Rho-associated coiled-coil containing protein kinase 2 BC Staff NeuroRx Inc. BGI Genomics Co. Ltd. Clover Biopharmaceuticals Day One Biopharmaceuticals LLC Merck...
BioCentury | Feb 18, 2021
Management Tracks

Day One names York COO, CFO; plus moves at Coherus, Antios, ArsenalBio, Affinia, Artelo and more

...BioCentury Staff After raising a $130 million series B round last week, pediatric oncology company Day One Biopharmaceuticals LLC...
...at APCO Worldwide LLC and Bartek is co-founder and president of the Friedreich’s Ataxia Research Alliance. BC Staff Day One Biopharmaceuticals LLC Coherus...
BioCentury | Feb 11, 2021
Product Development

With $130M series B, Day One explores new pediatric cancer targets as it prepares for launch

...target biology shared by pediatric and adult cancers, Day One Biopharmaceuticals LLC...
...in meeting those needs.” Karen Tkach Tuzman DAY101, TAK-580, mln2480 Day One Biopharmaceuticals LLC pediatric...
BioCentury | Oct 15, 2020
Finance

Larger stakes, more newcos as Canaan moves to bump up biopharma investments with new $800M fund

...novel biology or a new modality. Grant cited Day One Biopharmaceuticals LLC...
BioCentury | Sep 23, 2020
Management Tracks

Gilead BD head Bender takes top job at pediatric cancer start-up Day One

...across industry.Bender succeeds acting CEO Julie Grant, a Canaan general partner who is chairman of Day One Biopharmaceuticals LLC...
...VP of discovery chemistry at Array BioPharma Inc., is a venture partner at The Column Group. Karen Tkach Tuzman Day One Biopharmaceuticals LLC Jeremy...
BioCentury | Jun 5, 2020
Finance

In age of megafunds, Atlas stays the course with $400M twelfth venture fund

...allergy start-up is one of three board seats Gladstone holds. He is a director at Day One Biopharmaceuticals LLC...
BioCentury | May 22, 2020
Emerging Company Profile

With $60M, Canaan-incubated Day One seizes on under-appreciated advances in pediatric cancers

...infrastructure to make the former a driving force instead of an afterthought. Incubated by Canaan, Day One Biopharmaceuticals LLC...
...said Grant. “We’ve been surprised by breadth of what’s come in the door.” COMPANY PROFILE Day One Biopharmaceuticals LLC...
Items per page:
1 - 7 of 7
BioCentury | Feb 24, 2021
Deals

Feb. 23 Quick Takes: BGI raises $300M, plus a $230M C round for Clover, Day One, Waksal’s Graviton, Asalyxa

...KGaA dealOn the heels of a $130 million series B round led by RA Capital, Day One Biopharmaceuticals LLC...
...kinase kinase 2ROCK2 - Rho-associated coiled-coil containing protein kinase 2 BC Staff NeuroRx Inc. BGI Genomics Co. Ltd. Clover Biopharmaceuticals Day One Biopharmaceuticals LLC Merck...
BioCentury | Feb 18, 2021
Management Tracks

Day One names York COO, CFO; plus moves at Coherus, Antios, ArsenalBio, Affinia, Artelo and more

...BioCentury Staff After raising a $130 million series B round last week, pediatric oncology company Day One Biopharmaceuticals LLC...
...at APCO Worldwide LLC and Bartek is co-founder and president of the Friedreich’s Ataxia Research Alliance. BC Staff Day One Biopharmaceuticals LLC Coherus...
BioCentury | Feb 11, 2021
Product Development

With $130M series B, Day One explores new pediatric cancer targets as it prepares for launch

...target biology shared by pediatric and adult cancers, Day One Biopharmaceuticals LLC...
...in meeting those needs.” Karen Tkach Tuzman DAY101, TAK-580, mln2480 Day One Biopharmaceuticals LLC pediatric...
BioCentury | Oct 15, 2020
Finance

Larger stakes, more newcos as Canaan moves to bump up biopharma investments with new $800M fund

...novel biology or a new modality. Grant cited Day One Biopharmaceuticals LLC...
BioCentury | Sep 23, 2020
Management Tracks

Gilead BD head Bender takes top job at pediatric cancer start-up Day One

...across industry.Bender succeeds acting CEO Julie Grant, a Canaan general partner who is chairman of Day One Biopharmaceuticals LLC...
...VP of discovery chemistry at Array BioPharma Inc., is a venture partner at The Column Group. Karen Tkach Tuzman Day One Biopharmaceuticals LLC Jeremy...
BioCentury | Jun 5, 2020
Finance

In age of megafunds, Atlas stays the course with $400M twelfth venture fund

...allergy start-up is one of three board seats Gladstone holds. He is a director at Day One Biopharmaceuticals LLC...
BioCentury | May 22, 2020
Emerging Company Profile

With $60M, Canaan-incubated Day One seizes on under-appreciated advances in pediatric cancers

...infrastructure to make the former a driving force instead of an afterthought. Incubated by Canaan, Day One Biopharmaceuticals LLC...
...said Grant. “We’ve been surprised by breadth of what’s come in the door.” COMPANY PROFILE Day One Biopharmaceuticals LLC...
Items per page:
1 - 7 of 7